V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 330001437 | 330009503 | 1.83 | 63 | Palliative (P) | 2016-12-13 | 2017-01-12 | EW EuroEwing 2012 Arm B VDC | null | N | 330003626 | TRIAL |
| 330001438 | 330000807 | null | 8 | Curative (C) | 2017-04-14 | 2017-04-23 | NB HRNBL-1 COJEC Ind COURSE A | N | N | 330003634 | NOT MATCHED |
| 330001439 | 330000808 | 0 | 74 | null | 2015-04-23 | 2015-04-24 | NB HRNBL-1 COJEC Ind COURSE B | 01 | null | 330003635 | NOT MATCHED |
| 330001440 | 330000809 | 0 | null | Curative (C) | 2014-06-15 | 2014-06-15 | NB HRNBL-1 ch14.18/CHO only (trial) | 1 | N | 330003636 | NOT MATCHED |
| 330001441 | 330000809 | null | 45 | Curative (C) | 2015-07-03 | 2015-07-07 | ALL Interfant 06 Ind Erw asp 8-35 | N | N | 330003636 | NOT MATCHED |
| 330001442 | 330000810 | 1.67 | 61.5 | Not known (9) | 2015-05-28 | 2015-06-04 | CISPLATIN + DOCETAXEL + FLUOROURACIL | 02 | N | 330003638 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 330001443 | 330000811 | null | 79 | Curative (C) | 2017-06-07 | 2017-06-08 | Cisplatin + Docetaxel +Fluorouracil | N | N | 330003642 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 330001444 | 330000812 | null | 68.7 | Curative (C) | 2014-12-23 | 2014-12-23 | Trial Unspecified | 1 | N | 330003643 | TRIAL |
| 330001445 | 330000813 | 1.81 | 103 | Curative (C) | 2017-09-12 | 2017-10-06 | Cisplatin 7 day | N | Y | 330003644 | CISPLATIN |
| 330001446 | 330000814 | null | 26.4 | Curative (C) | 2017-05-24 | 2017-05-26 | NB HRNBL-1 COJEC Ind COURSE A | null | N | 330003651 | NOT MATCHED |
| 330001447 | 330000815 | null | 81 | Palliative (P) | null | 2018-02-09 | Trial Unspecified | Y | null | 330003652 | TRIAL |
| 330001448 | 330000815 | 1.7 | null | Not known (9) | 2015-02-16 | 2015-02-20 | CISPLATIN + DOCETAXEL + FLUOROURACIL | N | N | 330003652 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 330001449 | 330000815 | 0 | 83.4 | Curative (C) | 2018-02-25 | 2018-02-25 | LCHIV Cont A | null | N | 330003652 | NOT MATCHED |
| 330001450 | 330000815 | null | 85.2 | Disease modification (D) | 2014-07-25 | 2014-10-15 | CISPLATIN + DOCETAXEL + FLUOROURACIL | 02 | N | 330003652 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 330001451 | 330000815 | 1.74 | 68.1 | Curative (C) | 2016-07-08 | 2016-07-12 | CISPLATIN + DOCETAXEL + FLUOROURACIL | 02 | null | 330003652 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 330001452 | 330000816 | 0.75 | null | Curative (C) | 2014-07-26 | 2014-07-30 | NB HRNBL-1 COJEC Ind COURSE B | 01 | N | 330003669 | NOT MATCHED |
| 330001453 | 330000817 | 1.7 | 12.7 | Curative (C) | 2014-08-08 | 2014-09-03 | Cisplatin | N | Y | 330003675 | CISPLATIN |
| 330001454 | 330006481 | 0 | 77.2 | Curative (C) | 2014-11-02 | 2014-11-02 | NB HRNBL-1 COJEC Ind COURSE B | N | N | 330003677 | NOT MATCHED |
| 330001455 | 330000818 | 0 | 56.3 | Curative (C) | 2013-08-24 | 2013-08-29 | NB HRNBL-1 COJEC Ind COURSE A | Y | N | 330003678 | NOT MATCHED |
| 330001456 | 330000818 | 1.7 | 67.8 | Curative (C) | 2013-06-21 | 2013-07-17 | Cisplatin | N | Y | 330003678 | CISPLATIN |
| 330001458 | 330006483 | 1.64 | 56.9 | Curative (C) | 2015-10-05 | 2015-11-09 | Cisplatin 7 day | N | Y | 330003691 | CISPLATIN |
| 330001459 | 330006483 | 1.71 | null | null | 2013-07-09 | 2013-07-17 | Cisplatin + Docetaxel +Fluorouracil | N | N | 330003691 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 330001461 | 330000821 | 1.75 | 10.4 | Curative (C) | 2014-10-14 | 2014-11-09 | Cisplatin | 02 | N | 330003695 | CISPLATIN |
| 330001463 | 330000823 | 1.8 | 93 | Palliative (P) | 2015-03-04 | 2015-03-26 | Cisplatin + Docetaxel +Fluorouracil | N | N | 330003705 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 330001464 | 330000823 | 1.53 | 44.5 | Curative (C) | 2013-04-04 | 2013-04-21 | Cisplatin | N | null | 330003705 | CISPLATIN |
| 330001465 | 330000823 | 1.8 | 13.4 | Curative (C) | 2014-03-13 | 2014-03-21 | null | Y | N | 330003705 | NOT MATCHED |
| 330001466 | 330000823 | 1.66 | 19.2 | Curative (C) | 2016-08-20 | 2016-09-25 | Cisplatin | 02 | Y | 330003705 | CISPLATIN |
| 330001467 | 330000823 | null | 45.5 | null | 2015-03-16 | 2015-06-30 | Cisplatin + Docetaxel +Fluorouracil | null | N | 330003705 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 330001468 | 330000824 | 1.71 | 49.8 | Neo-adjuvant (N) | 2017-06-10 | 2017-06-21 | Cisplatin + Docetaxel +Fluorouracil | N | null | 330003719 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 330001469 | 330000825 | 1.68 | 74 | Neo-adjuvant (N) | 2013-02-08 | 2013-02-17 | Cisplatin + Docetaxel +Fluorouracil | N | N | 330003721 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 330001470 | 330000826 | 1.54 | 12.5 | Curative (C) | null | 2017-03-11 | Cisplatin | N | Y | 330003726 | CISPLATIN |
| 330001471 | 330000827 | 1.77 | 49.7 | Curative (C) | 2016-09-21 | 2016-09-26 | Cisplatin + Docetaxel +Fluorouracil | null | N | 330003728 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 330001472 | 330000827 | 1.73 | 54.4 | Curative (C) | 2013-03-13 | 2013-04-25 | Cisplatin | null | Y | 330003728 | CISPLATIN |
| 330001473 | 330000828 | 1.71 | 16.8 | Neo-adjuvant (N) | 2018-07-06 | 2018-07-15 | CISPLATIN + DOCETAXEL + FLUOROURACIL | 02 | null | 330003734 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 330001474 | 330000829 | 1.71 | 95.2 | Neo-adjuvant (N) | 2013-10-20 | 2013-10-25 | CISPLATIN + DOCETAXEL + FLUOROURACIL | 02 | N | 330003735 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 330001475 | 330000830 | 1.81 | null | Curative (C) | 2016-01-08 | 2016-01-09 | Cisplatin | N | Y | 330003736 | CISPLATIN |
| 330001476 | 330000830 | 0 | 52.2 | Palliative (P) | 2017-04-25 | 2017-05-02 | OST Euramos 1 Closed Trial - Ai | N | N | 330003736 | NOT MATCHED |
| 330001477 | 330000830 | 1.72 | 64 | Adjuvant (A) | 2015-03-13 | 2015-03-14 | Cisplatin | 02 | Y | 330003736 | CISPLATIN |
| 330001479 | 330000832 | 1.54 | 5.4 | Palliative (P) | 2016-03-18 | 2016-03-30 | EW EuroEwing 2012 Arm B VDC | 1 | N | 330004198 | TRIAL |
| 330001480 | 330000833 | null | 65 | Neo-adjuvant (N) | 2013-11-20 | 2013-11-22 | CISPLATIN + DOCETAXEL + FLUOROURACIL | 02 | N | 330004563 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 330001481 | 330000834 | 1.84 | 60.2 | Curative (C) | 2015-03-01 | 2015-03-05 | Trial Unspecified | Y | Y | 330004773 | TRIAL |
| 330001482 | 330006487 | 1.9 | 74.6 | Not known (9) | 2015-05-21 | 2015-06-13 | Cisplatin 7 day | 02 | Y | 330004787 | CISPLATIN |
| 330001483 | 330000835 | 1.69 | 77.2 | Neo-adjuvant (N) | 2017-06-19 | 2017-06-26 | CISPLATIN + DOCETAXEL + FLUOROURACIL | 2 | N | 330004796 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 330001484 | 330000835 | null | 65.8 | Curative (C) | 2015-01-10 | 2015-01-18 | CYCLOPHOSPHAMIDE + RITUXIMAB + prednisolone | Y | N | 330004796 | NOT MATCHED |
| 330001485 | 330000836 | null | 74.4 | Adjuvant (A) | 2016-11-28 | 2016-12-21 | Cisplatin | N | Y | 330004944 | CISPLATIN |
| 330001486 | 330000837 | 1.7 | 12.7 | Curative (C) | null | 2016-05-21 | Cisplatin | N | Y | 330004946 | CISPLATIN |
| 330001487 | 330000838 | 1.7 | 83 | Curative (C) | 2015-09-19 | 2015-09-29 | Cisplatin | N | Y | 330004948 | CISPLATIN |
| 330001488 | 330000838 | 1.6 | 20.7 | Disease modification (D) | 2014-12-15 | 2014-12-16 | NB HRNBL-1 COJEC Ind COURSE A | Y | N | 330004948 | NOT MATCHED |
| 330001489 | 330000838 | null | 99.5 | Curative (C) | 2013-09-22 | 2013-09-22 | NB Rel CCLG guidelines Irin & Temoz | Y | N | 330004948 | NOT MATCHED |
| 330001490 | 330000838 | 1.67 | 56.4 | Neo-adjuvant (N) | null | 2014-05-16 | Cisplatin + Docetaxel +Fluorouracil | N | N | 330004948 | CISPLATIN + DOCETAXEL + FLUOROURACIL |